SOTAC PHARMACEUTICALS Share price

The Company was originally formed and registered as a Partnership Firm under the Partnership Act 1932 (“Partnership Act”) in the name and style of “M/s Sotac Pharmaceuticals” pursuant to a deed of partnership dated October 28 2015. Thereafter "M/s. Sotac Pharmaceuticals” was converted from Partnership Firm to a Private Limited Company under Part I (Chapter XXI) of the Companies Act 2013 in the name of “Sotac Pharmaceuticals Private Limited” and received a certificate of incorporation dated December 18 2015 from the Assistant Registrar of Companies Gujarat. Later on the Company was converted into a Public Limited Company pursuant to shareholders resolution passed at Extra-ordinary General Meeting of the Company held on November 12 2022 and the name of the Company was changed to “Sotac Pharmaceuticals Limited”. A fresh Certificate of Incorporation consequent upon Conversion from Private Limited Company to Public Limited Company dated November 22 2022 was issued by the Registrar of Companies Ahmedabad.The Corporate Identification Number of the Company is U24230GJ2015PLC085451. SOTAC Pharmaceuticals Limited is part of SOTAC group based at Gujarat. the company has been founded by the visionary promoters Mr. Sharadkumar Dashrathbhai Patel Mr. Dineshkumar Babulal Gelot Mr. Vishalkumar Devrajbhai Patel Mr. Chetankumar Bachubhai Patel and Late Mr. Baldevbhai Trikambhai Jotania. One of the current promoters Mrs.Kiranben Baldevbhai Jotania wife of Late Mr. Baldevbhai Trikambhai Jotania acquired 409000 shares by way of transmission of shares due to his death.We are in business of manufacturing of pharmaceutical products for different marketers on loan license or contract manufacturing basis. the business is majorly on principle to principle basis with different marketers. As on the date of this Red Herring Prospectus we cater to 162 corporate clients on loan licence and/or contract manufacturing basis. The company has commenced manufacturing facility in year 2017 hence the company has experience of more than 5 years in the current line of business of the company. In year 2017 the company’s manufacturing facility was installed with capacity to manufacture 90 Crore tables / year 14 Crore Capsules / year. By focusing on the core competence we have witnessed multi-fold growth in the installed manufacturing capacity over period of 5 years. Therefore as on the date of this Red Herring Prospectus the manufacturing facility at SOTAC Pharmaceuticals Limited is installed with capacity to manufacture 360 Crore tables / year 32.40 Crore Capsules / year 2160 Kilo Litter syrup / year and 324 Tons external preparation / year. The promoters have a combined experience of more than 59 years in the pharmaceutical manufacturing Industry. Driven by the passion for building an integrated pharmaceutical company backed by their experience the Promoters have been the pillars of the Company's growth and have built a strong value system for the Company. With their enriching experience and progressive thinking we aim to continue to grow in the pharmaceutical industry.We have 71% holding in SOTAC Healthcare Private Limited (SOTAC Healthcare) and 100% of SOTAC Research Private Limited (SOTAC Research) thus making them the Subsidiary Companies. SOTAC Healthcare is engaged in the business of manufacturing of Beta-lactam drugs. SOTAC Research is engaged in the business of pharma molecule research and development. We have recently started a new venture namely SOTAC Lifescience Private Limited (SOTAC Lifescience). We hold 51% of total paid-up capital of SOTAC Lifescience. SOTAC Lifescience is a newly incorporated company and will be engaged in the business of Manufacturing of Nutraceuticals products and food products on contract-manufacturing basis. SOTAC Lifescience is in process of setting-up its manufacturing plant and yet not commenced commercial production.SOTAC Group is pharma manufacturer specializing in manufacturing of a wide range of pharmaceutical products such as Non Beta-Lactam (general) tablets Non Beta-Lactam (general) capsules Non Beta-lactam Syrup and external preparations through issuer company SOTAC Pharmaceuticals Limited. Beta-lactam coated tablets beta-lactam uncoated tablets betalactam capsules oral liquid dry syrup and external preparations such as nasal spray relief spray and cream through 71% subsidiary company through SOTAC Healthcare Private Limited. We will be commencing manufacturing of Nutraceuticals products and food products through newly incorporated 51% subsidiary SOTAC Lifescience Private Limited. the company is committed to provide a wide range of quality and affordable pharmaceutical products to a large number of healthcare professionals.The group’s therapeutic portfolio includes Anti-Diabetic Anti-Psychotic Vitamins Minerals Iron Anti-Cold AntiAllergic Derma Products Antacid Anti-Ulcerants PPI Anti-Emetics Cardiac Anti-Hypertensives Analgesic AntiPyretic Anti-Inflammatory Anti-Bacterial Anti-Viral General Antibiotics IP-Lactams & Non-IP-Lactams Anti-Fungal Cephalosporin.The group’s past and present clientele includes renowned pharma marketers and manufactures namely Cadila Pharma J. B. Chemical Lincoln Pharma Intas Pharma Viatris (Mylan) Makers (Ipca) Corona Remedies Eris Lifesciences Stride Pharma Stalion Pharma Acme Pharma Olecare Pharma Treatwell Pharma Ronak Healthcare Curever Pharma Kentoss Pharma Sunrest Pharma Ishan Healthcare etc.As a group we cater to a wide spectrum of companies for formulation development clinical batch production commercial scale productions. We intend to be the ideal partner for the clients and the aim is to deliver a diverse array of quality pharmaceutical products.The pharmaceutical manufacturing facilities are situated at Sanand GIDC–II in Ahmedabad district of Gujarat which offers easy and convenient accessibility. the infrastructure consists of comprehensive production unit quality control department quality assurance microbiological laboratory raw material and finished product storage. the group’s manufacturing facilities are WHO-GMP accredited. In past the manufacturing facility was also accredited with Kenya PPB and Ivory coast. SOTAC Pharmaceuticals Limited is also registered in USA with DUNS number.The Company has marked its presence in both domestic as well as global markets. the products are supplied in 14 major states in India. In-order-to capture growing demand for pharmaceutical products in international market and to create a more responsive and cost-effective supply chain we started the direct export operations in year 2022. Under vertical of direct selling we export products manufactured by us under the brand name directly to offshore distributors. the offshore business revenue is primarily derived from USA. The experience and trade relations developed by the promoters and management have been one of the key instrumental factors in the growth of the Company.We also market products manufactured by us under the Brand Name in domestic as well as offshore markets. As on the date of this Red Herring Prospectus the company has manufacturing permission for 329 products under license number G/25/2169 and 45 products under license number G/28/1587 from Food & Drug department for SOTAC Pharmaceuticals Limited. Further under the same licenses we are permitted to sale 34 Products in the name in offshore market also. The manufacturing units manufacture 56 under the own brands for Domestic market and 14 products are majorly sold in USA.As on the date of this Red Herring Prospectus the 71% subsidiary company has manufacturing permission for 335 products under license number G/28/1755 from Food & Drug department for SOTAC Healthcare Private Limited. Further under the same licenses we are permitted to sale 3 Products in the name in offshore market also.The Company is consistent in supplying quality products round the year. the products comply with requisite safety standards. We are a quality conscious company. We are constantly striving to expand the line of products and we are always looking for complementary products that will add to the range of products.MAJOR EVENTS :2015- The Company was incorporated as a private limited company under the name “Sotac Pharmaceuticals Private Limited” Limited”.2019- Recognised as “Fastest Growing Indian Company” with and Excellence Award by International Achievers Conference2021- Received “Indo Global award for Business Excellence”2022- The Company has acquired 5325000 Equity Shares in SOTAC Healthcare Private Limited making it subsidiary of the Company.- The Company has acquired 99995 Equity Shares in SOTAC Research Private Limited making it wholly owned subsidiary of the Company.- The Company was converted into Public Limited Company under the name of “Sotac Pharmaceuticals Limited”- Received recognition as for “Fastest Expansion of Project” by Sanand Industries Association (SIA)- Recognized as one of the “Top 10 Pharma Contract Manufacturers in India” by India Pharma Outlook